BioStone AsurDx™ iELISA for African Swine Fever Evaluated by FLI ASF Reference Laboratory and Published in Pathogens

News

Dallas – Forth Worth, TX — May 12, 2026  — BioStone Animal Health is pleased to announce that the AsurDx™ African Swine Fever Virus (ASFV) Antibody Indirect ELISA (iELISA) has been independently evaluated by the Friedrich-Loeffler-Institut (FLI), Germany’s National Reference Laboratory for African Swine Fever (ASF), with the study results published in the peer-reviewed scientific journal Pathogens. The…

BioStone Animal Health was Awarded Research Grant for Development of African swine fever (ASF) DIVA Tests

News

DALLAS-FORT WORTH, TX — October 29, 2024— BioStone Animal Health is pleased to announce that the GenScript Life Science Research Grant Program has awarded BioStone Animal Health a grant to investigate and develop DIVA diagnostics for African swine fever (ASF). GenScript Life Science Research Grant Program (www.genscript.com ), a new initiative dedicated to supporting breakthroughs in life…